This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Here are a few financially strong large-cap stocks that have a high Piotroski score of 9 Torrent Pharmaceuticals Limited With a market capitalization of Rs. crore, the shares of Torrent Pharmaceuticals Limited closed at Rs. Sun Pharmaceutical Industries Limited With a market capitalization of Rs. 2,745 crore in Q4 FY24 to Rs.
Emcure Pharmaceuticals Limited With a market cap of Rs. Emcure Pharmaceuticals Limited is one of the leading Indian pharmaceutical companies engaged in the business of developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. 1,230 on Monday.
The company is engaged in producing sulphur, ethanol, and boron chemicals used in industries like pharmaceuticals, textiles, polymers, water treatment, and agrochemicals. The company manufactures and sells specialty and commodity chemicals in India and internationally. Nahar Polyfilms Limited With a market capitalization of Rs.
It manufactures and markets glass containers, PET bottles, and packaging solutions for beverages, pharmaceuticals, cosmetics, and other industries. AGI Greenpac Limited was incorporated in 1960 and is a sustainable packaging products company based in Gurugram. Time Technoplast Limited With a market capitalization of Rs. per share, up by 1.32
911.85) Natco Pharma is a research-driven pharmaceutical company with a strong presence in niche therapeutic areas. The company operates across finished dosage formulations, active pharmaceutical ingredients (APIs), and contract manufacturing services, making it a vertically integrated player in the healthcare space.
Emcure Pharmaceuticals Emcure Pharmaceuticals Limited’s stock, with a market capitalisation of Rs. As of March 2025 , BC Investments IV held an 8.68% stake in Emcure Pharmaceuticals. Emcure Pharmaceuticals, headquartered in Pune, India, is a leading global pharmaceutical company founded by Satish Mehta.
Vishnu Chemicals Limited was incorporated in 1989 and is engaged in manufacturing, marketing, and exporting chromium chemicals and barium compounds, serving steel, glass, pharmaceutical, pigments, dyes, leather, and allied industries across 57 countries globally Capri Global Capital Limited With a market capitalization of Rs. 183.30.
Dr Reddy’s Laboratories Ltd Dr. Reddy’s Laboratories is a leading Indian pharmaceutical company known for manufacturing generic drugs, active pharmaceutical ingredients (APIs), and biosimilars. Headquartered in Hyderabad, the company serves markets across the U.S.,
Lupin ltd Lupin Limited, based in Mumbai, is a well-known pharmaceutical company with operations in more than 100 countries. Divis Laboratories Ltd Divis Laboratories Ltd is a leading pharmaceutical company based in India. It specializes in manufacturing active pharmaceutical ingredients (APIs) and intermediates used in medicines.
Alkem Laboratories Limited Alkem Laboratories develops and manufactures pharmaceutical products across diverse therapeutic areas through 21 facilities in India and USA. The net profit of the company has decreased by 32.97 percent, from Rs. 1,359 crore in FY23 to Rs. 911 crore in FY24.
Dr Reddy’s Laboratories Ltd Dr. Reddy’s Laboratories is a global pharmaceutical company based in India, specializing in manufacturing generic medications, active pharmaceutical ingredients (APIs), and biosimilars. Furthermore, the company’s debt-to-equity ratio is 0.22.
Here are three companies with a Six-months lock-in expiry on June 30, 2025 Senores Pharmaceuticals Limited With a market capitalization of Rs. crore, the shares of Senores Pharmaceuticals Limited were currently trading at Rs. On June 30, 2025, the six-month lock-in period for Senores Pharmaceuticals ends, unlocking 2.2
The company serves sectors like pharmaceuticals, agrochemicals, and industrial applications. Glenmark Pharmaceuticals Ltd Glenmark Pharmaceuticals is a global pharmaceutical company headquartered in India, focused on generics, specialty, and over-the-counter (OTC) products. 4,950 on May 15, 2023.
The Other segment encompasses the distribution of pharmaceutical products and the company’s agribusiness initiatives, reflecting Nava’s strategic diversification into healthcare and agriculture.
Cohance Lifesciences Cohance Lifesciences is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals, and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology, and chemical companies.
RPG Life Sciences RPG Life Sciences Limited is an integrated pharmaceutical company working in the development, manufacturing, and marketing of branded formulations, generics, and synthetic APIs, both in India and globally. The stock delivered an ROE and ROCE of 12.08 percent and 15.32 percent, respectively. percent and 35.95
Aarti Pharmalabs Limited was established in 2019 and is engaged in manufacturing active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives. It is also engaged in contract development and manufacturing services for global pharmaceutical companies. per equity share, down nearly 2.18
Healthcare & Pharmaceuticals Though never in the limelight, healthcare is a lucrative and essential industry. Here, billionaires are often pharmaceutical firms, healthcare device makers, or chains of hospitals. The COVID-19 pandemic helped speed up wealth generation in this sector, and it hasn’t let up.
Torrent Pharmaceuticals Limited Torrent Pharmaceuticals Limited was established in 1959 and is a leading Indian pharmaceutical company specializing in branded and generic medicines. The stock closed at Rs. in Friday’s session, reflecting a 3.16 percent decrease in the intraday trade. with strong volumes of 742.88 K shares.
Cipla A leading Indian multinational pharmaceutical company, founded in 1935, present in over 80 countries and recognised for affordable medicines and a humanitarian approach. Sun Pharmaceutical Industries India’s largest and the world’s fourth-largest speciality generic pharmaceutical company, operating in more than 100 countries.
Breakthroughs like GLP-1 drugs are already shifting how the market views pharmaceutical stocks. Tech influence is not limited to finance. The healthcare industry is also on the brink of major disruption. These developments could lead to big moves in healthcare stocks, so you will want to keep a close eye on this sector.
Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited was founded in 1907 and is an Indian multinational headquartered in Vadodara. It manufactures and markets pharmaceutical formulations, active pharmaceutical ingredients, and intermediates, with a strong presence in anti-infective drugs and global markets.
The company develops and produces pharmaceutical intermediates and specialty chemicals for agrochemicals, cosmetics, polymers, and exports globally, serving diverse industrial applications. In the June quarter of 2025, Vanguard Fund made a fresh stake of 1.09 percent in the company, which had a holding value of Rs. crore with ownership of 8.91
Aarti Pharmalabs Limited Aarti Pharmalabs Limited was established in 2022 following a demerger from Aarti Industries and is engaged in manufacturing active pharmaceutical ingredients (APIs), intermediates, and specialty chemicals, serving global pharmaceutical, biotechnology, and healthcare companies with integrated research-driven solutions.
Cipla Ltd Cipla Limited is a global pharmaceutical company headquartered in Mumbai, India, known for its wide range of medicines in respiratory, anti-retroviral, urology, cardiology, and other segments. The company is issuing a Final dividend of Rs. per equity share, representing a 1,045 percent payout over the face value of Rs. 10 per share.
However, the Pharma index bucked the trend and posted gains, led by a significant rally in Glenmark Pharmaceuticals after a favourable licensing agreement. Most sectoral indices ended in the red, with the IT and Media indices among the top losers due to weak earnings and broader market concerns.
Anuh Pharma Ltd Anuh Pharma Limited is engaged in the business of manufacturing active pharmaceutical ingredients (API). While the total investment value remains unchanged, shareholders receive more shares, promoting broader ownership and trading activity. Here are the stocks that are issuing a bonus in the coming week : 1.
RPG Life Sciences Limited is engaged in the business of manufacturing and marketing Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Further, the company reported a PAT of Rs. 183 crores, growing at a 3-year CAGR of around 53 percent between FY22 and FY25.
It manufactures and markets chemicals used in industries such as textiles, agriculture, and pharmaceuticals. Amal Limited Amal Ltd is a specialty chemical company and a subsidiary of Atul Ltd, part of the Lalbhai Group. With the Market Capitalization of Rs. company’s revenue rose by 132 percent from Rs. crores to Rs.
With a market capitalization of Rs 398 crore, the shares closed at Rs 50.5 per share, increase of around 2 percent as compared to the previous closing price.
Sai Life Science Limited was established in 1999 and is an innovator-focused contract research, development, and manufacturing organization providing end-to-end services in drug discovery, development, and manufacturing for global pharmaceutical and biotechnology companies. are their own, and not that of the website or its management.
Then we also have tariffs on autos, steel and aluminum, and upcoming tariffs on things like lumber and pharmaceuticals. China gets hit by a 34% tariff under this calculation, but thats above the already announced 20% tariffs on Chinese goods, which means tariffs on China are now at 54%.
Then we also have tariffs on autos, steel and aluminum, and upcoming tariffs on things like lumber and pharmaceuticals. China gets hit by a 34% tariff under this calculation, but thats above the already announced 20% tariffs on Chinese goods, which means tariffs on China are now at 54%.
And valuations have been, you know, with the exception of, of some of the obesity drugs, the pharmaceutical industry has been squashed by, by worries about regulations squashed by the power of the insurance companies, you know, squashed by patent, expire, you know, squashed by a lot, a lot of things.
Here are stocks that will trade ex-dividend in the coming week: Gland Pharma Ltd Gland Pharma Ltd is a prominent pharmaceutical company that specializes in the development, manufacturing, and marketing of injectable generic drugs. So investing in these stocks can provide you with passive income and growth in your portfolio over time.
This Week: Companies Reporting Earnings Monday: Vertex Pharmaceuticals Incorporated (VRTX) Tuesday: Apollo Global Management Inc. The forecasts or forward-looking statements are based on assumptions and may not materialize. The forecasts also are subject to revision. APO) Wednesday: Qualcomm Incorporated (QCOM), Gilead Sciences, Inc.
However, Eli Lillys strong market position and the expanding global healthcare demand position it well for sustained growth, especially in the pharmaceutical sector. That being said, Microsofts expansive tech offerings and dominance in the enterprise space outshine Lillys more niche position.
percent, delivers consistent profitability through its global pharmaceutical presence, supported by strong fundamentals and an attractive valuation. Marksans Pharma is a pharmaceutical company that develops and manufactures generic drugs, focusing on formulations in areas like oncology, cardiology, anti-diabetic, and pain management.
The company provide end-to-end services across the drug discovery, development and manufacturing value chain, for small-molecule NCE to global pharmaceutical innovator companies and biotechnology firms. Sai Life Sciences Limited is an innovator-focused contract research, development, and manufacturing organisation (CRDMO). on Friday.
This improves sectors like IT, textiles, pharmaceuticals, etc. Rupee versus export advantage Interestingly, the devaluation of the rupee (to some extent) benefits the exporters as they get more INR when they convert their dollar earnings.
Alongside these, several other companies like CRISIL, Hawkins Cookers, United Spirits, Alembic Pharmaceuticals, Taparia Tools, Data Patterns (India), and Apar Industries will also trade ex-dividend. 900% Alembic Pharmaceuticals Ltd 29 Jul 2025 ₹11.00 These generous returns have captured market attention. 380% DLF Ltd 28 Jul 2025 ₹6.00
Natco Pharma Ltd The pharmaceutical company NATCO Pharma Limited was founded in 1981 and is headquartered in Hyderabad. It is a well-known pharmaceutical company with a vertically integrated business model and a strong emphasis on research and development. With good revenue and profit growth, its EPS has grown at a 3-year CAGR of 187.2%
In contrast, the pharmaceutical and healthcare sectors weighed heavily on the market, underperforming due to significant declines in major stocks, indicating sector-specific concerns or profit-booking.
We organize all of the trending information in your field so you don't have to. Join 36,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content